ubmslatePT-logo-ubm

PT Mobile Logo

Search form

Topics:

Mark L. Fuerst

Mark L. Fuerst

Mark L. Fuerst is a freelance health and medical writer for ConsultantLive, Rheumatology Network, Psychiatric Times, and other UBM publications. He writes about rheumatology, psychiatry, neurology, endocrinology, oncology, and men’s health.

Posts by Author

The latest news in the treatment of depression covers patient self-management apps, antidepressant efficacy in older adults, and strategies to improve adherence.

New tools for the armamentarium: a patient self-management app, a retinal imaging system, and a computer program for Alzheimer diagnosis.

Are you up-to-date on the latest findings in mild cognitive impairment, dementia, and depression in elderly patients?

In a new study, an intensive lifestyle intervention did not markedly decrease A1c but had significant impact on need for medication.

Researchers investigate Alzheimer disease in 3 key areas: sleep, seizures, and proton pump inhibitors.

Study authors propose a new asthma patient “phenotype” in which a previous severe event is the sole predictor of another one.

Results of a recent study into the role of lipids in atopic asthma could help identify new targets for therapy.

New research suggests it’s possible to reverse the metabolic impact of childhood obesity and avert T2DM in adulthood.

Among the clues revealed in 3 recent studies: brain amyloid, saliva biomarkers, and microvascular dysfunction.

Find research on diabetes patients that could shift your thinking on home blood glucose monitoring; metformin efficacy in T1DM; and race and A1c.

Pages

By clicking Accept, you agree to become a member of the UBM Medica Community.